ANI Pharmaceuticals, Inc. (ANIP)

Last Closing Price: 58.26 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ANI Pharmaceuticals, Inc. (ANIP) had Net Income of $15.28M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$197.12M
Net Income
$15.28M
$73.04M
$124.08M
$170.93M
$26.19M
$-6.21M
$19.99M
$19.99M
$15.68M
$15.68M
$15.68M
$15.68M
$26.19M
$49.09M
19.61M
20.05M
$0.70
$0.69
Balance Sheet Financials
$536.29M
$58.18M
$756.14M
$1.29B
$201.81M
$611.63M
$647.14M
$848.96M
$418.62M
$-155.69M
$443.47M
21.67M
Cash Flow Statement Financials
$34.99M
$-19.85M
$-9.91M
$144.89M
$149.84M
$4.94M
$8.87M
--
$-0.41M
Fundamental Metrics & Ratios
2.66
--
--
0.58
1.40
62.95%
13.29%
13.29%
--
10.14%
7.75%
$32.52M
--
--
--
0.15
0.53
0.89
100.60
3.75%
-10.07%
1.21%
1.49%
$20.46
$1.62
$1.75